How do life sciences companies intend to leverage new and existing sources of growth? Explore the trajectory of life sciences transactions in our latest report.
EU Member States must implement the European Whistleblowing Directive (EU WBD) by 17 December 2021. However, only Denmark, Sweden and Portugal have passed their implementing legislation.
As digital transformation reshapes business models with different emphases across regions, digitally enabled strategies are helping companies transition from product-only offerings to product-service hybrids, orient to patient mapping, pre-diagnostics solutions and enhancing treatment administration.
Based on a survey of 900 employment and I&D leaders across the globe, the second installment of the Mind the Gap series outlines the main barriers to I&D success and the key actions organizations can take to strengthen performance, manage risk and accelerate progress through their I&D programs.
The European Whistleblowing Directive is to be implemented by the European Union’s 27 member states by no later than 17 December 2021 and will impact employers with operations in those jurisdictions. With most of the Member States yet to pass their implementing legislation, employers will face a period of intense activity in the coming months.
The emergence and subsequent spread of the Delta variant has led several countries, most notably the United States, into adopting more stringent health and safety protocols. On 29 July 2021, President Biden declared that the US government would be imposing vaccination requirements in certain cases and offering additional incentives for its citizens to be vaccinated. Following this announcement, TMT Talk revisits the important legal aspects of vaccinations, as they apply to the TMT sector.
As diversity and inclusion (D&I) has risen to the forefront of corporate agendas globally, pressure for organizations to accelerate progress around this space has been further intensified by recent social movements, rising stakeholder pressure and the disproportionate impact that COVID-19 has had on communities of color and women. Baker McKenzie examines the role that compliance leaders have to play in a report, in collaboration with Howlett Brown.
In an article published in Compliance and Risk Journal, we consider the data protection and privacy considerations in employee investigations and explain how to minimize associated risks for employers.
The use of algorithmic decision-making in recruitment to help improve the effectiveness and efficiency of process is unsurprisingly on the rise. Put simply this technology can enable companies to review far greater numbers of applications at speed, and, in theory, allow for an unbiased approach to recruitment decision making. However, as the UK Information Commissioner’s Office (ICO) has set out in its recent guidance on this topic, employers should take a critical and careful approach to when and how this technology is applied. If not applied carefully these tools can serve to actually exacerbate the inequalities that they are aiming to address, and could cause employers to fall foul of the UK’s equality and data protection legislation.
The news that a COVID-19 vaccine is on its way has given rise to hope that life will soon return to normal. Vaccinations in the workplace however are relatively uncommon and give rise to a number of tricky issues in the UK. This quick one-page overview provides insights into the key legal considerations and logistical challenges for employers.